Cargando…
Post-stroke inflammation—target or tool for therapy?
Inflammation is currently considered a prime target for the development of new stroke therapies. In the acute phase of ischemic stroke, microglia are activated and then circulating immune cells invade the peri-infarct and infarct core. Resident and infiltrating cells together orchestrate the post-st...
Autores principales: | Lambertsen, Kate Lykke, Finsen, Bente, Clausen, Bettina Hjelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482288/ https://www.ncbi.nlm.nih.gov/pubmed/30483945 http://dx.doi.org/10.1007/s00401-018-1930-z |
Ejemplares similares
-
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
por: Clausen, Bettina Hjelm, et al.
Publicado: (2016) -
Spontaneous ischaemic stroke lesions in a dog brain: neuropathological characterisation and comparison to human ischaemic stroke
por: Thomsen, Barbara Blicher, et al.
Publicado: (2017) -
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
por: von Linstow, Christian Ulrich, et al.
Publicado: (2021) -
Inflammation leads to distinct populations of extracellular vesicles from microglia
por: Yang, Yiyi, et al.
Publicado: (2018) -
Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice
por: Clausen, Bettina H, et al.
Publicado: (2008)